Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Lactobacilli for Vaginal Flora in Pregnancy
NCT04638257Phase 1Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jan 2013
- Primary completion
- Mar 2015
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 1, randomised, double-blind trial of lactobacillus rhamnosus gr-1 and limosilactobacillus fermentum RC-14 in bacterial vaginosis (BV) and preterm birth (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Number of participants with treatment-related adverse events at 60 days. Started Jan 2013; status: completed.
02
Drugs
lactobacillus rhamnosus gr-1limosilactobacillus fermentum RC-14
03
Conditions
bacterial vaginosis (BV)preterm birth
Beyond the preview
Go deeper on NCT04638257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04638257.